Comparison of the efficacy of dapagliflozin and linagliptin in the treatment of type 2 diabetes patients with normal body mass index and poor metformin monotherapy

• Main Authors: Mingli He (Author), Li Jiang (Author), Su Zhang (Author), Xinrong Yang (Author)
• Formato: Libro
• Publicado: World Scientific Publishing, 2024-01-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Objective: To explore the efficacy and safety of dapagliflozin and linagliptin in the treatment of type 2 diabetes patients (T2DM) with normal body mass index (BMI) who have poor single drug efficacy of metformin. Method: 102 T2DM patients with normal BMI who visited our hospital from December 2021...